CLASS II Device recall · Reported 6 Jan 2021 · FDA Enforcement Report

BD Phoenix PMIC/ID-108: IVD is intended recalled by Becton Dickinson &

Becton Dickinson & is recalling BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of, distributed nationwide in the US. The recall was initiated on 8 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll unexpired lots UDI: 00382904486082
Quantity recalled34825 eaches

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0762-2021
FDA event ID
86963
Recalling firm
Becton Dickinson &, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
8 Dec 2020
FDA classified
31 Dec 2020
Reported
6 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

8 Dec 2020Recall initiated by company
31 Dec 2020Classified by FDA+23 days
6 Jan 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448608

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of recalled?

Yes. Becton Dickinson & recalled BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of on 8 Dec 2020. The recall is Class II and its status is Terminated. Recall number Z-0762-2021.

Why was it recalled?

BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection

Which lots are affected?

All unexpired lots UDI: 00382904486082

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Test Kits & Diagnostics recalls

All 2,656